title: [The use of mildronat with stenocardia patients].
abstract: Against placebo background 50 patients with effort stenocardia received mildronate, a new native cardioactive drug and its effects on the clinical course in conditions of spirometric bicycle ergometry were studied. It was found that monotherapy with mildronate is accompanied by an antianginal effect and an increase of the physical working capacity of patients.
authors.forename: V A
authors.initials: VA
authors.lastname: Dudko
authors.forename: O A
authors.initials: OA
authors.lastname: Koshel'skaia
authors.forename: A A
authors.initials: AA
authors.lastname: Sokolov
mesh_terms: D000328:Adult; D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D005080:Exercise Test; D006801:Humans; D008297:Male; D008763:Methylhydrazines / Q000627:therapeutic use*; D008875:Middle Aged; D010807:Physical Endurance / Q000187:drug effects; D016032:Randomized Controlled Trials as Topic; D013147:Spirometry
chemical_list: D002317:Cardiovascular Agents; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate
vernacular_title: Primenenie mildronata u bol'nykh stenokardieĭ.